Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
neuropathy [2015/09/20 17:44]
sflitman [Response Form]
neuropathy [2016/11/01 14:37]
sflitman [Neuropathy]
Line 1: Line 1:
 ===== Neuropathy ===== ===== Neuropathy =====
  
-We have no currently enrolling trials, but will update this page when a new trial becomes available.+We have no currently enrolling trials ​for this indication, but will update this page when a new trial becomes available.
  
 <​html><​!-- <​html><​!--
 +
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
-Mild Cognitive Impairment and Mild AD | Intravenous anti-amyloid antibody ​ |  II  |  Yes  |  16%  |  52 weeks  |  1+ years  | +Diabetic Peripheral Neuropathy Pain | Novel oral agent  |  ​III  ​| ​ Yes  |  ​25%  |  12 weeks  |  ​52 weeks  | 
-| Moderate and Severe AD with Agitation  ​| Novel oral agent |  ​II  ​| ​ Yes  |  ​50%  |  12 weeks  |  ​24 weeks  | +
-| Mild AD | Intravenous ​ mAb antibody ​ |  III  |  Yes  |  50%  |  18 weeks  |   ​Yes ​  | +
-| Mild to Moderate AD | Oral nicotinic alpha-7 ligand |  III  |  Yes  |  33%  |  26 weeks  |  26 weeks  |+
 --></​html>​ --></​html>​
 +
 ====== Response Form ====== ====== Response Form ======
  
Print/export
QR Code
QR Code neuropathy (generated for current page)